{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:33:45Z","timestamp":1772764425467,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Homeobox B4 (HOXB4) is correlated with poor prognosis of various cancer types. However, how HOXB4 promotes ovarian cancer (OV) progression remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Cancer Genome Atlas (TCGA) database indicated that a high level of HOXB4 in OV was correlated with poor prognosis. The biological functions of HOXB4 were confirmed by colony formation, migration, and invasion assays. The effect of HOXB4 on the expression of EMT cell markers was determined. The transcriptional target of HOXB4 was DHDDS, which was detected by a ChIP assay. A xenograft tumor model was generated in nude mice to detect the role of HOXB4 in tumor proliferation and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that HOXB4 protein levels were higher in OV tissues than in normal tissues and correlated with poor prognosis of OV. HOXB4 reduction inhibited the proliferation and invasion ability of OV cells in vitro. Conversely, these effects were enhanced by the upregulation of HOXB4 in OV cells. The binding of HOXB4 to two DNA motifs regulated DHDDS expression and contributed to the malignant progression of OV. The role of HOXB4 in contributing to tumor development in vivo was verified in mice. Further results indicated that HOXB4 induced Snail and Zeb1 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, HOXB4 overexpression was remarkably correlated with poor prognosis of OV. Mechanistically, HOXB4 enhances the proliferation and invasion of tumor cells by activating DHDDS, thereby promoting the malignant progression of OV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-06725-4","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T11:06:57Z","timestamp":1584356817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["HOXB4 promotes the malignant progression of ovarian cancer via DHDDS"],"prefix":"10.1186","volume":"20","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-hai","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-juan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"6725_CR1","doi-asserted-by":"crossref","unstructured":"Yang J, Xing H, Lu D, Wang J, Li B, Tang J, Gu F, Hong L. Role of Jagged1\/STAT3 signalling in platinum-resistant ovarian cancer. J Cell Mol Med. 2019;23(6):4005\u201318.","DOI":"10.1111\/jcmm.14286"},{"key":"6725_CR2","doi-asserted-by":"crossref","unstructured":"Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol. 2019;221(2):136.e1\u2013136.e9.","DOI":"10.1016\/j.ajog.2019.04.005"},{"issue":"2","key":"6725_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000463","volume":"4","author":"RD Morgan","year":"2019","unstructured":"Morgan RD, Stamatopoulou S, Mescallado N, Saunders G, Welch R, Mitchell C, Hasan J, Clamp AR, Jayson GC. Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer. ESMO Open. 2019;4(2):e000463.","journal-title":"ESMO Open"},{"issue":"6","key":"6725_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3889\/oamjms.2019.129","volume":"7","author":"L Luh","year":"2019","unstructured":"Luh L, Nyoman BMI, Aag PW, Ketut A, Ayu B. Ovarian Cancer immature Teratoma type in pregnancy: management and Feto-maternal outcomes. Open Access Maced J Med Sci. 2019;7(6):1016\u201320.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"6725_CR5","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/s41598-019-42680-2","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Chanana P, Davila JI, Hou X, Zanfagnin V, McGehee CD, Goode EL, Polley EC, Haluska P, Weroha SJ, et al. Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts. Sci Rep. 2019;9(1):6314.","journal-title":"Sci Rep"},{"issue":"3","key":"6725_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/tbj.13268","volume":"25","author":"M Gentiluomo","year":"2019","unstructured":"Gentiluomo M, Villa C, Sommavilla E, Pesenti S, Parimbelli L, Bambina S, Valerii C, Sironi S. Inflammatory breast metastasis from primary advanced ovarian cancer. Breast J. 2019;25(3):507\u20139.","journal-title":"Breast J"},{"key":"6725_CR7","doi-asserted-by":"crossref","unstructured":"Garcia C, Harrison K, Ring KL, Sullivan MW, Rauh LA, Modesitt SC. Genetic counseling referral for ovarian cancer patients: a call to action. Familial Cancer. 2019;18(3):303\u20139.","DOI":"10.1007\/s10689-019-00129-5"},{"key":"6725_CR8","doi-asserted-by":"crossref","unstructured":"Daniele G, Arenare L, Scambia G, Pisano C, Sorio R, Breda E, De Placido S, Savarese A, Ferrandina G, Raspagliesi F, et al. Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials. Gynecol Oncol. 2019;154(1):83\u201388.","DOI":"10.1016\/j.ygyno.2019.04.012"},{"key":"6725_CR9","doi-asserted-by":"crossref","unstructured":"Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, Bray F, Soerjomataram I. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 2019;146(3):749\u201358.","DOI":"10.1002\/ijc.32322"},{"issue":"7661","key":"6725_CR10","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature22816","volume":"547","author":"X Ye","year":"2017","unstructured":"Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, Yang J, Weinberg RA. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547(7661):E1\u20133.","journal-title":"Nature"},{"key":"6725_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","volume":"391","author":"RL Pearlman","year":"2017","unstructured":"Pearlman RL, Montes de Oca MK, Pal HC, Afaq F. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma. Cancer Lett. 2017;391:125\u201340.","journal-title":"Cancer Lett"},{"issue":"1","key":"6725_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. Emt: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"4","key":"6725_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35(4):645\u201354.","journal-title":"Cancer Metastasis Rev"},{"issue":"14","key":"6725_CR14","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-17-0392","volume":"77","author":"J Antony","year":"2017","unstructured":"Antony J, Huang RY. AXL-driven EMT state as a targetable conduit in Cancer. Cancer Res. 2017;77(14):3725\u201332.","journal-title":"Cancer Res"},{"key":"6725_CR15","doi-asserted-by":"crossref","unstructured":"Han J, Meng J, Wang X, Yin S, Zhang Q, Liu H, Qin R, Li Z, Zhong W, Zhang C, et al. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79(7):1451\u201364.","DOI":"10.1158\/0008-5472.CAN-18-2238"},{"issue":"15","key":"6725_CR16","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1158\/0008-5472.CAN-17-3009","volume":"78","author":"J Meng","year":"2018","unstructured":"Meng J, Chen S, Han JX, Qian B, Wang XR, Zhong WL, Qin Y, Zhang H, Gao WF, Lei YY, et al. Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma. Cancer Res. 2018;78(15):4150\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"6725_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hep.23311","volume":"51","author":"T Sun","year":"2010","unstructured":"Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, Wang XH, Du J, Liu YX, Sun BC. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51(2):545\u201356.","journal-title":"Hepatology"},{"issue":"2","key":"6725_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/dgd.12199","volume":"57","author":"MK Kam","year":"2015","unstructured":"Kam MK, Lui VC. Roles of Hoxb5 in the development of vagal and trunk neural crest cells. Develop Growth Differ. 2015;57(2):158\u201368.","journal-title":"Develop Growth Differ"},{"issue":"8","key":"6725_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.archoralbio.2014.05.001","volume":"59","author":"FC Xavier","year":"2014","unstructured":"Xavier FC, Destro MF, Duarte CM, Nunes FD. Epigenetic repression of HOXB cluster in oral cancer cell lines. Arch Oral Biol. 2014;59(8):783\u20139.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"6725_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ydbio.2013.06.027","volume":"382","author":"M Vieux-Rochas","year":"2013","unstructured":"Vieux-Rochas M, Mascrez B, Krumlauf R, Duboule D. Combined function of HoxA and HoxB clusters in neural crest cells. Dev Biol. 2013;382(1):293\u2013301.","journal-title":"Dev Biol"},{"issue":"2","key":"6725_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1590\/S1678-77572011000200008","volume":"19","author":"R Tucci","year":"2011","unstructured":"Tucci R, Campos MS, Matizonkas-Antonio LF, Durazzo M. Pinto Junior Ddos S, Nunes FD: HOXB5 expression in oral squamous cell carcinoma. J Appl Oral Sci. 2011;19(2):125\u20139.","journal-title":"J Appl Oral Sci"},{"issue":"11","key":"6725_CR22","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1158\/1078-0432.CCR-10-2533","volume":"17","author":"WT Liao","year":"2011","unstructured":"Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, Bian XW, Deng YJ, Ding YQ. HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res. 2011;17(11):3569\u201378.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6725_CR23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1186\/s12885-018-4993-2","volume":"18","author":"PY Dumas","year":"2018","unstructured":"Dumas PY, Mansier O, Prouzet-Mauleon V, Koya J, Villacreces A, Brunet de la Grange P, Luque Paz D, Bidet A, Pasquet JM, Praloran V, et al. MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms. BMC Cancer. 2018;18(1):1098.","journal-title":"BMC Cancer"},{"issue":"6","key":"6725_CR24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3892\/ijo.2017.4151","volume":"51","author":"R Bonfim-Silva","year":"2017","unstructured":"Bonfim-Silva R, Ferreira Melo FU, Thome CH, Abraham KJ, De Souza FAL, Ramalho FS, Machado HR, De Oliveira RS, Cardoso AA, Covas DT, et al. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines. Int J Oncol. 2017;51(6):1929\u201340.","journal-title":"Int J Oncol"},{"issue":"6","key":"6725_CR25","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3892\/ijo.2016.3738","volume":"49","author":"H Wang","year":"2016","unstructured":"Wang H, Jia XH, Chen JR, Yi YJ, Wang JY, Li YJ, Xie SY. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562\/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K\/Akt signaling pathway. Int J Oncol. 2016;49(6):2529\u201337.","journal-title":"Int J Oncol"},{"issue":"9","key":"6725_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11626-016-0055-8","volume":"52","author":"JL Dos Santos Schiavinato","year":"2016","unstructured":"Dos Santos Schiavinato JL, Oliveira LH, Araujo AG, Orellana MD, de Palma PV, Covas DT, Zago MA, Panepucci RA. TNF-alpha and notch signaling regulates the expression of HOXB4 and GATA3 during early T lymphopoiesis. In Vitro Cell Dev Biol Anim. 2016;52(9):920\u201334.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"20","key":"6725_CR27","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1089\/scd.2015.0063","volume":"24","author":"M Fournier","year":"2015","unstructured":"Fournier M, Lebert-Ghali CE, Bijl JJ. HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4. Stem Cells Dev. 2015;24(20):2413\u201322.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"6725_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.stemcr.2018.01.009","volume":"10","author":"N Teichweyde","year":"2018","unstructured":"Teichweyde N, Kasperidus L, Carotta S, Kouskoff V, Lacaud G, Horn PA, Heinrichs S, Klump H. HOXB4 promotes Hemogenic endothelium formation without perturbing endothelial cell development. Stem Cell Reports. 2018;10(3):875\u201389.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"6725_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/leu.2015.189","volume":"30","author":"X Huang","year":"2016","unstructured":"Huang X, Lee MR, Cooper S, Hangoc G, Hong KS, Chung HM, Broxmeyer HE. Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression. Leukemia. 2016;30(1):144\u201353.","journal-title":"Leukemia"},{"issue":"5","key":"6725_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/stem.1631","volume":"32","author":"SH Hong","year":"2014","unstructured":"Hong SH, Yang SJ, Kim TM, Shim JS, Lee HS, Lee GY, Park BB, Nam SW, Ryoo ZY, Oh IH. Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness. Stem Cells. 2014;32(5):1313\u201322.","journal-title":"Stem Cells"},{"issue":"9","key":"6725_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040959","volume":"7","author":"T Fujiwara","year":"2012","unstructured":"Fujiwara T, Yokoyama H, Okitsu Y, Kamata M, Fukuhara N, Onishi Y, Fujimaki S, Takahashi S, Ishizawa K, Bresnick EH, et al. Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells. PLoS One. 2012;7(9):e40959.","journal-title":"PLoS One"},{"issue":"19","key":"6725_CR32","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1182\/blood-2011-12-396754","volume":"119","author":"R Fan","year":"2012","unstructured":"Fan R, Bonde S, Gao P, Sotomayor B, Chen C, Mouw T, Zavazava N, Tan K. Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells. Blood. 2012;119(19):e139\u201347.","journal-title":"Blood"},{"key":"6725_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2018.04.033","volume":"663","author":"Y Li","year":"2018","unstructured":"Li Y, Sun J, Gao S, Hu H, Xie P. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells. Gene. 2018;663:9\u201316.","journal-title":"Gene"},{"issue":"14","key":"6725_CR34","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang LG, He QY. ChIPseeker: an R\/bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31(14):2382\u20133.","journal-title":"Bioinformatics"},{"issue":"11\u201312","key":"6725_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1387\/ijdb.180157sg","volume":"62","author":"SJ Gaunt","year":"2018","unstructured":"Gaunt SJ. Mouse embryo Hox gene enhancers assayed in cell culture: Hoxb4, b8 and a7 are activated by Cdx1 protein. Int J Dev Biol. 2018;62(11\u201312):717\u201322.","journal-title":"Int J Dev Biol"},{"issue":"2","key":"6725_CR36","first-page":"326","volume":"24","author":"L Li","year":"2016","unstructured":"Li L, Zhao CT, Cui BL, Wu SL, Liu XD, Su Z, Yang J, Wang W, Cui ZG, Zhao HG. Expression of HOXB4, PRDM16 and HOXA9 in patients with acute myeloid leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(2):326\u201331.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"10","key":"6725_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164555","volume":"11","author":"S Jorgensen","year":"2016","unstructured":"Jorgensen S, Coskun M, Homburg KM, Pedersen OB, Troelsen JT. HOXB4 gene expression is regulated by CDX2 in intestinal epithelial cells. PLoS One. 2016;11(10):e0164555.","journal-title":"PLoS One"},{"issue":"5","key":"6725_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/CJI.0000000000000039","volume":"37","author":"A Nanbakhsh","year":"2014","unstructured":"Nanbakhsh A, Pochon C, Amsellem S, Pittari G, Tejchman A, Bourhis JH, Chouaib S. Enhanced cytotoxic activity of ex vivo-differentiated human natural killer cells in the presence of HOXB4. J Immunother. 2014;37(5):278\u201382.","journal-title":"J Immunother"},{"issue":"3","key":"6725_CR39","first-page":"703","volume":"20","author":"Y Qiao","year":"2012","unstructured":"Qiao Y, Zhao CT, Liu ZZ, Feng XQ, Wang L, Liu SH. Construction of lentivirus vector containing human homeobox gene HOXB4 and its expression in human umbilical cord mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012;20(3):703\u20139.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"4","key":"6725_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4196\/kjpp.2012.16.4.265","volume":"16","author":"SW Park","year":"2012","unstructured":"Park SW, Won KJ, Lee YS, Kim HS, Kim YK, Lee HW, Kim B, Lee BH, Kim JH, Kim DK. Increased HoxB4 inhibits apoptotic cell death in pro-B cells. Korean J Physiol Pharmacol. 2012;16(4):265\u201371.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"3","key":"6725_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/stem.1036","volume":"30","author":"LM Forrester","year":"2012","unstructured":"Forrester LM, Jackson M. Mechanism of action of HOXB4 on the hematopoietic differentiation of embryonic stem cells. Stem Cells. 2012;30(3):379\u201385.","journal-title":"Stem Cells"},{"issue":"6","key":"6725_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003524","volume":"9","author":"C Deng","year":"2013","unstructured":"Deng C, Li Y, Liang S, Cui K, Salz T, Yang H, Tang Z, Gallagher PG, Qiu Y, Roeder R, et al. USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription. PLoS Genet. 2013;9(6):e1003524.","journal-title":"PLoS Genet"},{"issue":"2","key":"6725_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12013-012-9349-y","volume":"63","author":"L Wen-jun","year":"2012","unstructured":"Wen-jun L, Qu-lian G, Hong-ying C, Yan Z, Mei-Xian H. Studies on HOXB4 expression during differentiation of human cytomegalovirus-infected hematopoietic stem cells into lymphocyte and erythrocyte progenitor cells. Cell Biochem Biophys. 2012;63(2):133\u201341.","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"6725_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.scr.2011.09.001","volume":"8","author":"K Tashiro","year":"2012","unstructured":"Tashiro K, Kawabata K, Omori M, Yamaguchi T, Sakurai F, Katayama K, Hayakawa T, Mizuguchi H. Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction. Stem Cell Res. 2012;8(2):300\u201311.","journal-title":"Stem Cell Res"},{"issue":"2","key":"6725_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/stem.782","volume":"30","author":"M Jackson","year":"2012","unstructured":"Jackson M, Axton RA, Taylor AH, Wilson JA, Gordon-Keylock SA, Kokkaliaris KD, Brickman JM, Schulz H, Hummel O, Hubner N, et al. HOXB4 can enhance the differentiation of embryonic stem cells by modulating the hematopoietic niche. Stem Cells. 2012;30(2):150\u201360.","journal-title":"Stem Cells"},{"issue":"1","key":"6725_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-018-0844-7","volume":"17","author":"H Liang","year":"2018","unstructured":"Liang H, Zhao X, Wang C, Sun J, Chen Y, Wang G, Fang L, Yang R, Yu M, Gu Y, et al. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. Mol Cancer. 2018;17(1):96.","journal-title":"Mol Cancer"},{"issue":"1","key":"6725_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s13277-015-3852-x","volume":"37","author":"J Yan","year":"2016","unstructured":"Yan J, Zhang Y, Shi W, Ren C, Liu Y, Pan Y. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas. Tumour Biol. 2016;37(1):823\u20138.","journal-title":"Tumour Biol"},{"issue":"1","key":"6725_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-014-0072-1","volume":"14","author":"J Gao","year":"2014","unstructured":"Gao J, Zhu Y, Nilsson M, Sundfeldt K. TGF-beta isoforms induce EMT independent migration of ovarian cancer cells. Cancer Cell Int. 2014;14(1):72.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"6725_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-10-2550","volume":"71","author":"J Wu","year":"2011","unstructured":"Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, Narita M, Muller W, Liu J, Wei JJ. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res. 2011;71(2):349\u201359.","journal-title":"Cancer Res"},{"issue":"2","key":"6725_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ajhg.2011.01.001","volume":"88","author":"S Zuchner","year":"2011","unstructured":"Zuchner S, Dallman J, Wen R, Beecham G, Naj A, Farooq A, Kohli MA, Whitehead PL, Hulme W, Konidari I, et al. Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa. Am J Hum Genet. 2011;88(2):201\u20136.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"6725_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ajhg.2011.01.002","volume":"88","author":"L Zelinger","year":"2011","unstructured":"Zelinger L, Banin E, Obolensky A, Mizrahi-Meissonnier L, Beryozkin A, Bandah-Rozenfeld D, Frenkel S, Ben-Yosef T, Merin S, Schwartz SB, et al. A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews. Am J Hum Genet. 2011;88(2):207\u201315.","journal-title":"Am J Hum Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-06725-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T20:49:27Z","timestamp":1615841367000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6725"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06725-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18907\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18907\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18907\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in this study were granted ethical and legal approval prior to the beginning of the study. All procedures performed in this study involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee (IACUC) at West China Second University Hospital. The clinical results presented in this study are from the TCGA database. TCGA has signed informed consent with the patient, and we thank TCGA in the acknowledgements section.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}